Author

Vladimir Lazarević

Lund UniversityORCID 0000-0002-1782-4423Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:ATAC-seq· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:experimental assay· 1

Frequent Co-Authors

Sören LehmanniD· 2 shared Akifumi Takaori‐KondoiD· 1 shared Akinori YodaiD· 1 shared Albin ÖsterroosiD· 1 shared Anna RobeliusiD· 1 shared Ayana KoniD· 1 shared Bénédicte Piauger· 1 shared Carl SandéniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Sören LehmannORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintMay 24, 2026

Chromatin landscape and epigenetic heterogeneity of acute myeloid leukemia

Yotaro Ochi, Markus Liew-Littorin, Yasuhito Nannya…·Seishi Ogawa

This study identifies 16 AML subgroups based on chromatin accessibility profiles using ATAC-seq in 1,563 cases, revealing epigenetic heterogeneity and its clinical and therapeutic implications.

DOI 10.64898/2026.03.22.711973

humanscATAC-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 12, 2025

The cellular state space of AML unveils novel NPM1 subtypes with distinct clinical outcomes and immune evasion properties

Henrik Lilljebjörn, Pablo Peña‐Martínez, Hanna Thorsson…·Thoas Fioretos

This study uses single-cell RNA sequencing to identify novel NPM1 subtypes in AML with distinct clinical outcomes and immune evasion properties.

DOI 10.1101/2025.02.12.637826

humanscRNA-seq

𝕏 PostBluesky